Institutional investors purchased a net $1.2 million shares of BIOC during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 8.62% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HOWE & RUSLING, INC. Bought 1.2 Thousand shares of Biocept Inc
METLIFE SECURITIES, INC. Sold 400.00 shares of Biocept Inc
CREATIVE PLANNING, INC. Sold 1.1 Thousand shares of Biocept Inc